Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - YMAB

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - YMAB

  • Market Cap$1.575bn
  • SymbolNASDAQ:YMAB
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS9842411095

Company Profile

Y-mAbs Therapeutics Inc is a late-stage clinical biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Products developed by the company include naxitamab for the treatment of pediatric patients with relapsed or refractory and radiolabeled omburtamab for the treatment of pediatric patients with central nervous system.

Latest YMAB news

Currently there for this company. Visit our news hub for other news .